Literature DB >> 19359660

Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms.

Carla Iacobini1, Stefano Menini, Carlo Ricci, Angela Scipioni, Viola Sansoni, Samantha Cordone, Maurizio Taurino, Matteo Serino, Giuseppe Marano, Massimo Federici, Flavia Pricci, Giuseppe Pugliese.   

Abstract

OBJECTIVE: Modified lipoproteins, particularly oxidized LDLs, are believed to evoke an inflammatory response which participates in all stages of atherosclerosis. Disposal of these particles is mediated through receptors which may trigger proinflammatory signaling pathways leading to vascular injury. This study was aimed at assessing the role in atherogenesis of one of these receptors, galectin-3. METHODS AND
RESULTS: Galectin-3-deficient and wild-type mice were fed an atherogenic diet or standard chow for 8 months. Lesion area and length were higher in galectin-3-deficient versus wild-type mice. At the level of the aortic sinus, wild-type animals showed only fatty streaks, whereas galectin-3-deficient mice developed complex lesions, associated with extensive inflammatory changes. This was indicated by the presence of T lymphocytes with activated Th1-phenotype and by more marked monocyte-macrophage infiltration, inflammatory mediator expression, vascular cell apoptosis, and proinflammatory transcription factor activation. Increased accumulation of oxidixed LDLs and lipoxidation products and upregulation of other receptors for these compounds, including the proinflammatory RAGE, were detected in galectin-3-deficient versus wild-type mice.
CONCLUSIONS: These data suggest a unique protective role for galectin-3 in the uptake and effective removal of modified lipoproteins, with concurrent downregulation of proinflammatory pathways responsible for atherosclerosis initiation and progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19359660     DOI: 10.1161/ATVBAHA.109.186791

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  36 in total

1.  Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies.

Authors:  Christiane Drechsler; Graciela Delgado; Christoph Wanner; Katja Blouin; Stefan Pilz; Andreas Tomaschitz; Marcus E Kleber; Alexander Dressel; Christoph Willmes; Vera Krane; Bernhard K Krämer; Winfried März; Eberhard Ritz; Wiek H van Gilst; Pim van der Harst; Rudolf A de Boer
Journal:  J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 10.121

2.  Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance.

Authors:  Pingping Li; Shuainan Liu; Min Lu; Gautum Bandyopadhyay; Dayoung Oh; Takeshi Imamura; Andrew M F Johnson; Dorothy Sears; Zhufang Shen; Bing Cui; Lijuan Kong; Shaocong Hou; Xiao Liang; Salvatore Iovino; Steven M Watkins; Wei Ying; Olivia Osborn; Joshua Wollam; Martin Brenner; Jerrold M Olefsky
Journal:  Cell       Date:  2016-11-03       Impact factor: 41.582

3.  Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study.

Authors:  Abayomi Oyenuga; Aaron R Folsom; Oluwaseun Fashanu; David Aguilar; Christie M Ballantyne
Journal:  Angiology       Date:  2018-06-07       Impact factor: 3.619

4.  Transcriptional analysis of the endothelial response to diabetes reveals a role for galectin-3.

Authors:  April L Darrow; Ralph V Shohet; J Gregory Maresh
Journal:  Physiol Genomics       Date:  2011-07-26       Impact factor: 3.107

Review 5.  The roles of Galectin-3 in autoimmunity and tumor progression.

Authors:  Gordana Radosavljevic; Vladislav Volarevic; Ivan Jovanovic; Marija Milovanovic; Nada Pejnovic; Nebojsa Arsenijevic; Daniel K Hsu; Miodrag L Lukic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

6.  D-Carnosine octylester attenuates atherosclerosis and renal disease in ApoE null mice fed a Western diet through reduction of carbonyl stress and inflammation.

Authors:  Stefano Menini; Carla Iacobini; Carlo Ricci; Angela Scipioni; Claudia Blasetti Fantauzzi; Andrea Giaccari; Enrica Salomone; Renato Canevotti; Annunziata Lapolla; Marica Orioli; Giancarlo Aldini; Giuseppe Pugliese
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

7.  Relationship of galectin-3 with obesity, IL-6, and CRP in women.

Authors:  J Pang; V T Nguyen; D H Rhodes; M E Sullivan; C Braunschweig; G Fantuzzi
Journal:  J Endocrinol Invest       Date:  2016-07-21       Impact factor: 4.256

8.  Adipose tissue-specific modulation of galectin expression in lean and obese mice: evidence for regulatory function.

Authors:  Davina H Rhodes; Maria Pini; Karla J Castellanos; Trinidad Montero-Melendez; Dianne Cooper; Mauro Perretti; Giamila Fantuzzi
Journal:  Obesity (Silver Spring)       Date:  2013-02       Impact factor: 5.002

Review 9.  Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies.

Authors:  Giovanni Musso; Maurizio Cassader; Roberto Gambino
Journal:  Nat Rev Drug Discov       Date:  2016-01-22       Impact factor: 84.694

10.  FL-926-16, a novel bioavailable carnosinase-resistant carnosine derivative, prevents onset and stops progression of diabetic nephropathy in db/db mice.

Authors:  Carla Iacobini; Stefano Menini; Claudia Blasetti Fantauzzi; Carlo M Pesce; Andrea Giaccari; Enrica Salomone; Annunziata Lapolla; Marica Orioli; Giancarlo Aldini; Giuseppe Pugliese
Journal:  Br J Pharmacol       Date:  2017-12-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.